Brief: Hybrigenics' Stemcis Gets FDA Clearance For Medical Devices
27/06/2022 16:50
June 27 (Reuters) - HYBRIGENICS SA ALHYG.PA :
* STEMCIS OBTAINS FDA CLEARANCE TO MARKET ITS MEDICAL
DEVICES IN
THE UNITED STATES
Source text for Eikon: ID:nACT75170
Further company coverage: ALHYG.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587 696 600;))
Recent news on Aton SA
See all newsBrief: Hybrigenics SA Says Hybrigenics Re-Brands To 'Aton', Commits EUR 15Million To Support Its New Growth And Development Strategy Over Next Three Years
Brief: Hybrigenics 2022 Net Loss EUR 0.5 Million
Brief: Hybrigenics Presents Progress Of B Cell Design Subsidiary
Brief: Hybrigenics Targets EUR 60 Mln Of Turnover By 2025
Brief: Hybrigenics H1 Operating Loss Widens To EUR 0.2 Million